Acquisition of a new flow cytometer for advanced cellular analysis
CytoFLEX LX flow cytometer
This study is about getting a new, advanced machine to help scientists at Johns Hopkins University better understand diseases like Alzheimer's and cancer by analyzing cells more effectively, which means they can gather important information with fewer experiments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10854278 on NIH RePORTER |
What this research studies
This research involves the purchase of a state-of-the-art CytoFLEX LX flow cytometer to enhance cellular analysis capabilities at Johns Hopkins University. The new instrument will replace an outdated model and will allow for more experimental modalities, including the ability to measure smaller particles and analyze multiple parameters simultaneously. This advancement will support various ongoing research projects, including those focused on Alzheimer's disease progression and cancer treatment, ultimately leading to better data and insights from fewer experiments.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals diagnosed with Alzheimer's disease or cancer.
Not a fit: Patients with conditions unrelated to cellular analysis or those not diagnosed with Alzheimer's disease or cancer may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for conditions like Alzheimer's disease and cancer.
How similar studies have performed: Previous research utilizing advanced flow cytometry techniques has shown promising results in understanding complex cellular interactions and disease mechanisms.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Dobbie, Ian Michael — Johns Hopkins University
- Study coordinator: Dobbie, Ian Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.